Thomson Reuters/Uni...
Health Care: Drugs
Ariad Pharmaceuticals (ARIA: NASDAQ)
$16.67 0.20 | 1.21%
05/17/13 - 04:00 PM ET
Insider Trading
| Historical Data | Current | 1 Mo. Ago | 2 Mo. Ago | 3 Mo. Ago | 4 Mo. Ago | 5 Mo. Ago | 6 Mo. Ago |
|---|---|---|---|---|---|---|---|
| Net Insider Transaction | 174,486 | 220,875 | 81,939 | -105,968 | -123,967 | -140,567 | -57,628 |
| Shares Bought | 646,105 | 538,273 | 149,439 | 93,550 | 150,394 | 215,106 | 193,747 |
| Shares Sold | 471,619 | 317,398 | 67,500 | 199,518 | 274,361 | 355,673 | 251,375 |
Institutional Trading
| Historical Data | Current | 1 Mo. Ago | 2 Mo. Ago | 3 Mo. Ago | 4 Mo. Ago | 5 Mo. Ago | 6 Mo. Ago |
|---|---|---|---|---|---|---|---|
| Total Shares Held | 147.80M | 135.66M | 135.34M | 136.35M | 134.00M | 133.60M | 132.01M |
| Shares Bought | 30.46M | 23.73M | 23.35M | 23.62M | 22.23M | 20.07M | 19.80M |
| Shares Sold | 23.18M | 22.65M | 22.00M | 21.98M | 15.61M | 15.80M | 15.58M |
Portfolios with ARIA
- Portfolio NameUser Type
- ProSteven Cohen - SAC Capital
- ProDaniel Loeb - Third Point
- ContributorBreakout Stocks Of The Week...
- ContributorEarnings Short Squeeze Play...
- ContributorEarnings Short Squeeze Play...
- ContributorStocks Rising On Unusual Vo...
- ContributorStocks Rising On Unusual Vo...
- Contributor7 Cancer Drug Stocks to Kno...
- ContributorStocks At New 52-Week Highs...
- ContributorStocks Rising On Unusual Vo...
Latest ARIA Headlines from TheStreet
- Biotech Stock Mailbag: MannKind, Ariad, Oncolytics Biotech 04.05.13 | 07:04 am
- Ariad CEO Strikes Back, Insists Leukemia Drug Is Fine 04.04.13 | 10:04 am
- Ariad Stock Falls On Unusually High Volume (ARIA) 04.03.13 | 02:04 pm
- The Survey Says: Ariad's Leukemia Drug Is Toxic 04.03.13 | 01:04 pm
- Most Profitable Second Quarter Biotech Stocks 04.02.13 | 06:04 am
- Ariad Pharmaceuticals (ARIA): Drugs' Highlighted Dud Of The Day 03.28.13 | 05:03 pm
- Ariad Pharma Falls On Weak Leukemia Drug Prescriptions 03.27.13 | 12:03 pm
- Ariad Stock Falls On Unusually High Volume (ARIA) 03.25.13 | 04:03 pm
- Cramer's Top Stock Picks: ARIA ALKS LINE KORS WFM 02.28.13 | 06:02 am
- Cramer's 'Mad Money' Recap: I Told You So 02.27.13 | 08:02 pm
Press Releases for ARIA
- ARIAD Announces That Iclusig™ (Ponatinib) Receives Positive CHMP Opinion For Approval In The European Union - Business Wire 03.22.13 | 08:03 am
- ARIAD Announces Presentations Of Preclinical Data At American Association For Cancer Research Annual Meeting - Business Wire 03.20.13 | 07:03 am
- ARIAD To Present At Barclays Global Healthcare Conference - Business Wire 03.06.13 | 07:03 am
- ARIAD To Present At The Cowen And Company 33rd Annual Health Care Conference - Business Wire 02.28.13 | 07:02 am
- ARIAD Reports 2012 Financial Results And Outlines Key Objectives For 2013 - Business Wire 02.25.13 | 07:02 am
- Jonathan E. Dickinson, General Manager, ARIAD Pharmaceuticals (Europe), Sàrl (Photo: Business Wire) - Business Wire 02.21.13 | 02:02 am
- ARIAD To Present At The RBC Capital Markets Healthcare Conference - Business Wire 02.19.13 | 07:02 am
- ARIAD To Present At The Leerink Swann Global Healthcare Conference - Business Wire 02.08.13 | 07:02 am
- ARIAD To Webcast Conference Call On Fourth Quarter And Year-End 2012 Financial Results - Business Wire 02.05.13 | 07:02 am
- ARIAD Announces Completion Of Public Offering - Business Wire 01.29.13 | 04:01 pm
Partner Headlines for ARIA
- Pre-Market Earnings Report for February 25, 2013 : LOW, FE, HTZ, DCI, KOS, ARIA, DDD, BGC, CTB, CWH, HL, DNDN - NASDAQ 02.22.13 | 09:02 pm
- Mid-Week Biopharma Catalyst Trades To Consider - Seeking Alpha 12.13.12 | 09:12 am
- UPDATE: Dawson James Initiates Coverage on Ariad Pharmaceuticals with Market Outperform Rating, $32 PT - Benzinga 12.07.12 | 09:12 am
- Data Published on ARIAD Candidate - Analyst Blog - Zacks 11.30.12 | 02:11 pm
- 5 Bio-Pharmas On The Rise With Potential Groundbreaking And Lifesaving Treatments - Seeking Alpha 10.09.12 | 09:10 am
- ARIAD Seeks Ponatinib Approval - Analyst Blog - Zacks 10.02.12 | 06:10 pm
- ARIAD Partner Withdraws PMA - Analyst Blog - NASDAQ 09.19.12 | 08:09 pm
- 5 Pharmaceutical Companies With EMA Catalysts During The Next 3 - 12 Months - Part II - Seeking Alpha 09.02.12 | 08:09 am
- ARIAD Seeks EU Nod for Ponatinib - Analyst Blog - NASDAQ 08.31.12 | 10:08 pm
- ARIAD Seeks EU Nod for Ponatinib - Analyst Blog - Zacks 08.31.12 | 06:08 pm
